You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 20, 2024

Investigational Drug Information for Clemizole


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Clemizole?

Clemizole is an investigational drug.

There have been 4 clinical trials for Clemizole. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2022.

The most common disease conditions in clinical trials are Syndrome, Epilepsies, Myoclonic, and Hepatitis A. The leading clinical trial sponsors are Epygenix, Eiger BioPharmaceuticals, and GreenLight Clinical PTY LTD.

There are three hundred and forty US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Clemizole
TitleSponsorPhase
EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome.EpygenixPhase 2
EPX-100 (Clemizole Hydrochloride) as Add-on Therapy to Control Convulsive Seizures in Patients With Dravet SyndromeGreenLight Clinical PTY LTDPhase 2
EPX-100 (Clemizole Hydrochloride) as Add-on Therapy to Control Convulsive Seizures in Patients With Dravet SyndromeEpygenixPhase 2

See all Clemizole clinical trials

Clinical Trial Summary for Clemizole

Top disease conditions for Clemizole
Top clinical trial sponsors for Clemizole

See all Clemizole clinical trials

US Patents for Clemizole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Clemizole ⤷  Sign Up Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP) ⤷  Sign Up
Clemizole ⤷  Sign Up .beta.-D-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-C-substituted-2-modified-N.s- up.6-substituted purine nucleotides for HCV treatment Atea Pharmaceuticals, Inc. (Boston, MA) ⤷  Sign Up
Clemizole ⤷  Sign Up Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) ⤷  Sign Up
Clemizole ⤷  Sign Up 1',4'-thio nucleosides for the treatment of HCV IDENIX PHARMACEUTICALS LLC (Cambridge, MA) ⤷  Sign Up
Clemizole ⤷  Sign Up .beta.-D-2'-deoxy-2'-.alpha.-fluoro-2'.beta.-C-substituted-2-modified-N.su- p.6-substituted purine nucleotides for HCV treatment Atea Pharmaceuticals, Inc. (Boston, MA) ⤷  Sign Up
Clemizole ⤷  Sign Up Benzimidazole derivatives Enanta Pharmaceuticals, Inc. (Watertown, MA) ⤷  Sign Up
Clemizole ⤷  Sign Up Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Clemizole

Drugname Country Document Number Estimated Expiration Related US Patent
Clemizole Canada CA2961033 2034-09-11 ⤷  Sign Up
Clemizole European Patent Office EP3192791 2034-09-11 ⤷  Sign Up
Clemizole Japan JPWO2016039408 2034-09-11 ⤷  Sign Up
Clemizole World Intellectual Property Organization (WIPO) WO2016039408 2034-09-11 ⤷  Sign Up
Clemizole Australia AU2016229966 2035-03-06 ⤷  Sign Up
Clemizole Australia AU2018282469 2035-03-06 ⤷  Sign Up
Clemizole Australia AU2020203055 2035-03-06 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.